Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE studyPremal H Thaker, Tirza Areli Calderón Boyle, Sara Burns, Jonathan Lim, John Hartman, Linda V Kalilani, Jeanne M Schilder, Jean A Hurteau, Amanda K Golembesky
7 September 2024
Are we making progress in curing advanced cervical cancer—again?Jacob Christian Lindegaard, Primoz Petric, Li-Tee Tan, Peter Hoskin, Maximilian P Schmid, Ina Jürgenliemk-Schulz, Umesh Mahantshetty, Christian Kirisits, Richard Pötter
10 July 2024
Intraoperative imaging of residual ovarian cancer after neoadjuvant chemotherapy using indocyanine greenPatriciu Achimas-Cadariu, Paul Milan Kubelac, Andrei Pasca, Vlad Alexandru Gata, Bogdan Fetica, Ovidiu Balacescu, Eva Fischer-Fodor, Monica Focsan, Simion Astilean, Catalin Ioan Vlad
4 November 2024
Comparing visual inspection with acetic acid, with and without Lugol’s Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trialSelamawit Fisseha Mekuria, Habtamu Biazin, Tamrat Abebe, Christer Borgfeldt, Nahom Assegid, Adane Mihret, Reta Obsi Nemomsa, Ola Forslund, Mats Jerkeman
3 October 2024
Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and EuropeKathleen N Moore, Mansoor R Mirza, Charlie Gourley, Sandro Pignata, Domenica Lorusso, Bradley J Monk, Jalid Sehouli, Jeanne M Schilder, Nathalie D'Esquermes, Antonio González-Martín
20 August 2024
ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomyRamon Rovira, Liliana Mereu, François Planchamp, Henrik Falconer, Ahmed El-Balat, Marc Barahona, Anna Fagotti, Denis Querleu, Cagatay Taskiran
24 September 2024
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, Yoo Young Lee, Myong Cheol Lim, Sung-Jong Lee, Kyung-Jin Min, Kyung Jin Eoh, Kwang Beom Lee, Min Kyu Kim, Jae Yun Song, Seung-Hyuk Shim, Yong Il Ji, Yong-Joong Song, Suk-Joon ChangSee the full list of authors
20 August 2024
Tumoral programmed cell death 1 (PD1) expression in endometrial carcinoma is a prognostic marker for patient outcomeBarin Feroz, Teresa L Pan, Katharina Leitner, Christoph Ebner, Katharina Steger, Wanja Kildal, Gunnar Kristensen, Alain Gustave Zeimet, Hubert Hackl, Heidi Fiegl, Christian Marth, Verena Wieser
5 July 2024
Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysisMengmeng Chen, Ling Han, Yisi Wang, Yali Chen, Ai Zheng
13 September 2024
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, Amit M Oza, Jennifer O’Donnell, Katherine Bennett, Ros Glaspool, Chee Khoon Lee, Josee-Lyne Ethier, Philipp Harter, Veronika Seebacher-Shariat, Ting-Chang Chang, Paul A Cohen, Toon van Gorp, Adriana Chavez-BlancoSee the full list of authors
4 November 2024